Elequin Capital’s Zimmer Biomet ZBH Stock Holding History

Elequin Capital’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-156	Closed	-$19.9K	–	545
2022 Q4	$19.9K	Buy	+156	New	+$18.1K	0.01%	400

Other funds holding ZBH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Elequin Capital's ZBH Position: Q1 2023 in Review

Elequin Capital sold out of Zimmer Biomet (ZBH) in Q1 2023, closing a stake of 156 shares — an estimated $19.9K sold.

Elequin Capital first reported a position in ZBH in Q4 2022 and held it in 1 quarter. The position peaked at $19.9K in Q4 2022. 993 funds tracked by Wall St. Rank hold ZBH as of Q1 2023.

Elequin Capital reported no remaining Zimmer Biomet position as of Q1 2023 after selling out during the quarter.
Elequin Capital sold 156 Zimmer Biomet shares in Q1 2023, an estimated $19.9K.
Elequin Capital first reported a position in Zimmer Biomet in Q4 2022 and held it in 1 quarter.
Elequin Capital's Zimmer Biomet position peaked at $19.9K in Q4 2022.
993 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2023.

Based on Elequin Capital's 13F filing for Q1 2023, filed 11 May 2023.